Literature DB >> 10706089

Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells.

A Hoeflich1, O Fettscher, H Lahm, W F Blum, H J Kolb, D Engelhardt, E Wolf, M M Weber.   

Abstract

Increased concentrations of insulin-like growth factor-binding protein-2 (IGFBP-2) have been observed in human malignancies including adrenocortical carcinomas. To elucidate the functional consequences of IGFBP-2 overexpression, we have stably transfected the cDNA of murine IGFBP-2 in mouse adrenocortical tumor cells (Y-1). Long-term overexpression of IGFBP-2 was associated with significant morphological alterations, enhanced cell proliferation, and increased cloning efficiency as compared with mock transfected control cells. The enhanced proliferation of IGFBP-2 secreting clones was independent of exogenous insulin-like growth factors (IGFs). These data suggest that elevated levels of IGFBP-2 may contribute to the highly malignant phenotype of adrenocortical cancer by a thus far unknown, presumably IGF-independent, mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706089

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

2.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

Review 3.  Adrenocortical tumors and hyperplasias in childhood--etiology, genetics, clinical presentation and therapy.

Authors:  Jennifer A Sutter; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2006-09

4.  Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition.

Authors:  Xavier Terrien; Elise Bonvin; Sophie Corroyer; Olivier Tabary; Annick Clement; Alexandra Henrion Caude
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3.

Authors:  Toshiro Migita; Tadahito Narita; Reimi Asaka; Erika Miyagi; Hiroko Nagano; Kimie Nomura; Masaaki Matsuura; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Hiroyuki Seimiya; Yuichi Ishikawa
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

6.  Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling.

Authors:  Adda Grimberg; Carrie M Coleman; Zonggao Shi; Timothy F Burns; Timothy K MacLachlan; Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2006-10-30       Impact factor: 4.742

7.  Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.

Authors:  Liang-Hui Shi; Xiao-Qun Zhu; Guo-Hai Zhao; Ya-Bin Xia; Yi-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.

Authors:  Zonggao Shi; Maria J Henwood; Peter Bannerman; Dalia Batista; Anelia Horvath; Marta Guttenberg; Constantine A Stratakis; Adda Grimberg
Journal:  Growth Horm IGF Res       Date:  2007-02-05       Impact factor: 2.372

9.  IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.

Authors:  Sonya W Song; Gregory N Fuller; Asadullah Khan; Shouming Kong; Weiping Shen; Ellen Taylor; Latha Ramdas; Frederick F Lang; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

10.  Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2.

Authors:  Ping La; Robert W Schnepp; Clark D Petersen; Albert C Silva; Xianxin Hua
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.